[1]
|
Dass, S.A., Tan, K.L., Selva Rajan, R., Mokhtar, N.F., Mohd Adzmi, E.R., Wan Abdul Rahman, W.F., Al-Astani Tengku Din, T.A.D. and Balakrishnan, V. (2021) Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities. Medicina, 57, Article No. 62. https://doi.org/10.3390/medicina57010062
|
[2]
|
Pal, T., Bonner, D., Cragun, D., Monteiro, A.N.A., Phelan, C., Servais, L., Kim, J., Narod, S.A., Akbari, M.R. and Vadaparampil, S.T. (2015) A High Frequency of BRCA Mutations in Young Black Women with Breast Cancer Residing in Florida. Cancer, 121, 4173-4180. https://doi.org/10.1002/cncr.29645
|
[3]
|
Cruz-Lozano, M., González-González, A., Marchal, J.A., Munoz-Muela, E., Molina, M.P., Cara, F.E., Brown, A.M., Garcia-Rivas, G., Hernandez-Brenes, C., Lorente, J.A., Sanchez-Rovira, P., Chang, J.C. and Granados-Principal, S. (2019) Hydroxytyrosol Inhibits Cancer Stem Cells and the Metastatic Capacity of Triple-Negative Breast Cancer Cell Lines by the Simultaneous Targeting of Epithelial-to-Mesenchymal Transition, Wnt/β-Catenin and TGFβ Signaling Pathways. European Journal of Nutrition, 58, 3207-3219. https://doi.org/10.1007/s00394-018-1864-1
|
[4]
|
Dittmer, J. (2018) Breast Cancer Stem Cells: Features, Key Drivers and Treatment Options. Seminars in Cancer Biology, 53, 59-74. https://doi.org/10.1016/j.semcancer.2018.07.007
|
[5]
|
Chung, B.-M., Rotty, J.D. and Coulombe, P.A. (2013) Networking Galore: Intermediate Filaments and Cell Migration. Current Opinion in Cell Biology, 25, 600-612. https://doi.org/10.1016/j.ceb.2013.06.008
|
[6]
|
Strouhalova, K., Přechová, M., Gandalovičová, A., Brábek, J., Gregor, M. and Rosel, D. (2020) Vimentin Intermediate Filaments as Potential Target for Cancer Treatment. Cancers, 12, Article No. 184. https://doi.org/10.3390/cancers12010184
|
[7]
|
Strietz, J., Stepputtis, S.S., Follo, M., Bronsert, P., Stickeler, E. and Maurer, J. (2021) Human Primary Breast Cancer Stem Cells Are Characterized by Epithelial-Mesen-chymal Plasticity. International Journal of Molecular Sciences, 22, Article No. 1808. https://doi.org/10.3390/ijms22041808
|
[8]
|
Villard, A.V., Genna, A., Lambert, J., Volpert, M., Noel, A., Hollier, B., Polette, M., Vanwynsberghe, A.M. and Gilles, C. (2022) Regulation of Tissue Factor by CD44 Supports Coagulant Activity in Breast Tumor Cells. Cancers, 14, Article No. 3288. https://doi.org/10.3390/cancers14133288
|
[9]
|
Vitale, D., Kumar Katakam, S., Greve, B., Jang, B., Oh, E.-S., Alaniz, L. and Götte, M. (2019) Proteoglycans and Glycosaminoglycans as Regulators of Cancer Stem Cell Function and Therapeutic Resistance. The FEBS Journal, 286, 2870-2882. https://doi.org/10.1111/febs.14967
|
[10]
|
Balkwill, F. (2004) Cancer and the Chemokine Network. Nature Reviews Cancer, 4, 540-550. https://doi.org/10.1038/nrc1388
|
[11]
|
Lagerström, M.C. and Schiöth, H.B. (2008) Structural Diversity of G Protein-Coupled Receptors and Significance for Drug Discovery. Nature Reviews Drug Discovery, 7, 339-357. https://doi.org/10.1038/nrd2518
|
[12]
|
Murdoch, C. (2000) CXCR4: Chemokine Receptor Extraordinaire. Immunological Reviews, 177, 175-184. https://doi.org/10.1034/j.1600-065X.2000.17715.x
|
[13]
|
Teicher, B.A. and Fricker, S.P. (2010) CXCL12 (SDF-1)/CXCR4 Pathway in Cancer. Clinical Cancer Research, 16, 2927-2931. https://doi.org/10.1158/1078-0432.CCR-09-2329
|
[14]
|
Wang, J., Tannous, B.A., Poznansky, M.C. and Chen, H. (2020) CXCR4 Antagonist AMD3100 (Plerixafor): From an Impurity to a Therapeutic Agent. Pharmacological Research, 159, Article ID: 105010. https://doi.org/10.1016/j.phrs.2020.105010
|
[15]
|
Chen, I.X., Chauhan, V.P., Posada, J., Ng, M.R., Wu, M.W., Adstamongkonkul, P., Huang, P., Lindeman, N., Langer, R. and Jain, R.K. (2019) Blocking CXCR4 Alleviates Desmoplasia, Increases T-Lymphocyte Infiltration, and Improves Immunotherapy in Metastatic Breast Cancer. Proceedings of the National Academy of Sciences of the United States of America, 116, 4558-4566. https://doi.org/10.1073/pnas.1815515116
|
[16]
|
Simó, R., Sáez-López, C., Barbosa-Desongles, A., Hernández, C. and Selva, D.M. (2015) Novel Insights in SHBG Regulation and Clinical Implications. Trends in Endocrinology & Metabolism, 26, 376-383. https://doi.org/10.1016/j.tem.2015.05.001
|
[17]
|
Goldštajn, M.S., Toljan, K., Grgić, F., Jurković, I. and Baldani, D.P. (2016) Sex Hormone Binding Globulin (SHBG) as a Marker of Clinical Disorders. Collegium Antropologicum, 40, 211-218.
|
[18]
|
Nounu, A., Kar, S.P., Relton, C.L. and Richmond, R.C. (2022) Sex Steroid Hormones and Risk of Breast Cancer: A Two-Sample Mendelian Randomization Study. Breast Cancer Research, 24, Article No. 66. https://doi.org/10.1186/s13058-022-01553-9
|
[19]
|
Watts, E.L., Perez-Cornago, A., Fensom, G.K., Smith-Byrne, K., Noor, U., Andrews, C.D., Gunter, M.J., Holmes, M.V., Martin, R.M., Tsilidis, K.K., Albanes, D., Barricarte, A., Bueno-de-Mesquita, B., Chen, C., Cohn, B.A., Dimou, N.L., Ferrucci, L., Flicker, L., Freedman, N.D., Giles, G.G., Giovannucci, E.L., Goodman, G.E., Haiman, C.A., Hankey, G.J., Huang, J., Huang, W.Y., Hurwitz, L.M., Kaaks, R., Knekt, P., Kubo, T., Langseth, H., Laughlin, G., Le Marchand, L., Luostarinen, T., MacInnis, R.J., Mäenpää, H.O., Männistö, S., Metter, E.J., Mikami, K., Mucci, L.A., Olsen, A.W., Ozasa, K., Palli, D., Penney, K.L., Platz, E.A., Rissanen, H., Sawada, N., Schenk, J.M., Stattin, P., Tamakoshi, A., Thysell, E., Tsai, C.J., Tsugane, S., Vatten, L., Weiderpass, E., Weinstein, S.J., Wilkens, L.R., Yeap, B.B., Allen, N.E., Key, T.J. and Travis, R.C. (2022) Circulating Free Testosterone and Risk of Aggressive Prostate Cancer: Prospective and Mendelian Randomisation Analyses in International Consortia. International Journal of Cancer, 151, 1033-1046. https://doi.org/10.1002/ijc.34116
|
[20]
|
Varsavsky, M., Reyes-García, R., García-Martín, A., González-Ramírez, A.R., Avilés-Perez, M.D. and Muñoz-Torres, M. (2013) SHBG Levels Are Associated with Bone Loss and Vertebral Fractures in Patients with Prostate Cancer. Osteoporosis International, 24, 713-719. https://doi.org/10.1007/s00198-012-2012-z
|
[21]
|
Duarte-Costa, S., Castro-Ferreira, R., Neves, J.S. and Leite-Moreira, A.F. (2014) S100A1: A Major Player in Cardiovascular Performance. Physiological Research, 63, 669-681. https://doi.org/10.33549/physiolres.932712
|
[22]
|
Diaz-Romero, J. and Nesic, D. (2017) S100A1 and S100B: Calcium Sensors at the Cross-Roads of Multiple Chondrogenic Pathways. Journal of Cellular Physiology, 232, 1979-1987. https://doi.org/10.1002/jcp.25720
|
[23]
|
Wang, G., Li, H.-N., Cui, X.-Q., Xu, T., Dong, M.-L., Li, S.-Y. and Li, X.-R. (2021) S100A1 Is a Potential Biomarker for Papillary Thyroid Carcinoma Diagnosis and Prognosis. Journal of Cancer, 125, 760-5771. https://doi.org/10.7150/jca.51855
|
[24]
|
Xing, W., Zhao, Y., Lin, L., Zhao, Z., Yang, M., Wang, N., Cui, S., Bai, R. and Zhao, A. (2022) Overexpression of S100A1 in Osteosarcoma Inhibits Tumor Proliferation and Progression. Iranian Journal of Public Health, 51, 2773-2782. https://doi.org/10.18502/ijph.v51i12.11468
|
[25]
|
Young, B.D., Yu, W., Rodríguez, D.J.V., Varney, K.M., MacKerell Jr., A.D. and Weber, D.J. (2021) Specificity of Molecular Fragments Binding to S100B versus S100A1 as Identified by NMR and Site Identification by Ligand Competitive Saturation (SILCS). Molecules, 26, Article No. 381. https://doi.org/10.3390/molecules26020381
|
[26]
|
Eryilmaz, U., Demirci, B., Aksun, S., Boyacioglu, M., Akgullu, C., Ilgenli, T.F., Yalinkilinc, H.S. and Bilgen, M. (2015) S100A1 as a Potential Diagnostic Biomarker for Assessing Cardiotoxicity and Implications for the Chemotherapy of Certain Cancers. PLOS ONE, 10, e0145418. https://doi.org/10.1371/journal.pone.0145418
|
[27]
|
Zhang, S., Wang, Z., Liu, W., Lei, R., Shan, J., Li, L. and Wang, X. (2017) Distinct Prognostic Values of S100 mRNA Expression in Breast Cancer. Scientific Reports, 7, Article No. 39786. https://doi.org/10.1038/srep39786
|
[28]
|
Hatoum, D., Yagoub, D., Ahadi, A., Nassif, N.T. and McGowan, E.M. (2017) Annexin/S100A Protein Family Regulation through p14ARF-p53 Activation: A Role in Cell Survival and Predicting Treatment Outcomes in Breast Cancer. PLOS ONE, 12, e0169925. https://doi.org/10.1371/journal.pone.0169925
|
[29]
|
Zhao, S.-B., Dean, N., Gao, X.-D. and Fujita, M. (2020) MON2 Guides Wntless Transport to the Golgi through Recycling Endosomes. Cell Structure and Function, 45, 77-92. https://doi.org/10.1247/csf.20012
|
[30]
|
Li, Y., Yang, C., Liu, Z., Du, S., Can, S., Zhang, H., Zhang, L., Huang, X., Xiao, Z., Li, X., Fang, J., Qin, W., Sun, C., Wang, C., Chen, J. and Chen, H. (2022) Integrative Analysis of CRISPR Screening Data Uncovers New Opportunities for Optimizing Cancer Immunotherapy. Molecular Cancer, 21, Article No. 2. https://doi.org/10.1186/s12943-021-01462-z
|
[31]
|
Ron, D., Chen, C.H., Caldwell, J., Jamieson, L., Orr, E. and Mochly-Rosen, D. (1994) Cloning of an Intracellular Receptor for Protein Kinase C: A Homolog of the Beta Subunit of G Proteins. Proceedings of the National Academy of Sciences of the United States of America, 91, 839-843. https://doi.org/10.1073/pnas.91.3.839
|
[32]
|
Berns, H., Humar, R., Hengerer, B., Kiefer, F.N. and Battegay, E.J. (2000) RACK1 Is up-Regulated in Angiogenesis and Human Carcinomas. The FASEB Journal, 14, 2549-2558. https://doi.org/10.1096/fj.99-1038com
|
[33]
|
Janßen, U., Davis, E.M., Le Beau, M.M. and Stoffel, W. (1997) Human Mitochondrial Enoyl-CoA Hydratase Gene (ECHS1): Structural Organization and Assignment to Chromosome 10q26.2-q26.3. Genomics, 40, 470-475. https://doi.org/10.1006/geno.1996.4597
|
[34]
|
Liu, X., Feng, R. and Du, L. (2010) The Role of Enoyl-CoA Hydratase Short Chain 1 and Peroxiredoxin 3 in PP2-Induced Apoptosis in Human Breast Cancer MCF-7 Cells. FEBS Letters, 584, 3185-3192. https://doi.org/10.1016/j.febslet.2010.06.002
|
[35]
|
Zhao, Q.-M., Kuang, F., Wu, H. and Zhang, Y.-H. (2015) Attenuation of Enoyl Coenzyme A Hydratase 1 Expression in Colorectal Cancer Cells Using Small Interfering RNA Inhibits Cell Proliferation and Migration. Molecular Medicine Reports, 12, 470-474. https://doi.org/10.3892/mmr.2015.3418
|
[36]
|
Gong, X., Zhu, Y., Dong, J., Chen, J., You, J., Zheng, Q., Rao, Z., Mao, Q. and Jiang, J. (2013) Small Hepatitis B Surface Antigen Interacts with and Modulates Enoyl-Coenzyme A Hydratase Expression in Hepatoma Cells. Archives of Virology, 158, 1065-1070. https://doi.org/10.1007/s00705-012-1581-7
|
[37]
|
Uchiumi, T., Fotovati, A., Sasaguri, T., Shibahara, K., Shimada, T., Fukuda, T., Nakamura, T., Izumi, H., Tsuzuki, T., Kuwano, M. and Kohno, K. (2006) YB-1 Is Important for an Early Stage Embryonic Development: Neural Tube Formation and Cell Proliferation. Journal of Biological Chemistry, 281, 40440-40449. https://doi.org/10.1074/jbc.M605948200
|
[38]
|
Jürchott, K., Kuban, R.-J., Krech, T., Blüthgen, N., Stein, U., Walther, W., Friese, C., Kiełbasa, S.M., Ungethüm, U., Lund, P., Knösel, T., Kemmner, W., Morkel, M., Fritzmann, J., Schlag, P.M., Birchmeier, W., Krueger, T., Sperling, S., Sers, C., Royer, H.D., Herzel, H. and Schäfer, R. (2010) Identification of Y-Box Binding Protein 1 As a Core Regulator of MEK/ERK Pathway-Dependent Gene Signatures in Colorectal Cancer Cells. PLOS Genetics, 6, e1001231. https://doi.org/10.1371/journal.pgen.1001231
|
[39]
|
Matsumoto, K. and Bay, B.H. (2005) Significance of the Y-Box Proteins in Human Cancers. Journal of Molecular and Genetic Medicine, 1, 11-17. https://doi.org/10.4172/1747-0862.1000005
|
[40]
|
Ma, Y., Chen, Y. and Petersen, I. (2017) Expression and Epigenetic Regulation of Cystatin B in Lung Cancer and Colorectal Cancer. Pathology—Research and Practice, 213, 1568-1574. https://doi.org/10.1016/j.prp.2017.06.007
|
[41]
|
Jin, X., Wei, Y., Xu, F., Zhao, M., Dai, K., Shen, R., Yang, S. and Zhang, N. (2018) SIRT1 Promotes Formation of Breast Cancer through Modulating Akt Activity. Journal of Cancer, 9, 2012-2023. https://doi.org/10.7150/jca.24275
|
[42]
|
Pelicano, H., Zhang, W., Liu, J., Hammoudi, N., Dai, J., Xu, R.-H., Pusztai, L. and Huang, P. (2014) Mitochondrial Dysfunction in Some Triple-Negative Breast Cancer Cell Lines: Role of mTOR Pathway and Therapeutic Potential. Breast Cancer Research, 16, Article No. 434. https://doi.org/10.1186/s13058-014-0434-6
|
[43]
|
Evans, K.W., Yuca, E., Scott, S.S., Zhao, M., Paez Arango, N., Cruz Pico, C.X., Saridogan, T., Shariati, M., Class, C.A., Bristow, C.A., Vellano, C.P., Zheng, X., Gonzalez-Angulo, A.M., Su, X., Tapia, C., Chen, K., Akcakanat, A., Lim, B., Tripathy, D., Yap, T.A., Francesco, M.E.D., Draetta, G.F., Jones, P., Heffernan, T.P., Marszalek, J.R. and Meric-Bernstam, F. (2021) Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer. Cancer Research, 81, 5572-5581. https://doi.org/10.1158/0008-5472.CAN-20-3242
|
[44]
|
Krämer, A., Green, J., Pollard Jr., J. and Tugendreich, S. (2014) Causal Analysis Approaches in Ingenuity Pathway Analysis. Bioinformatics, 30, 523-530. https://doi.org/10.1093/bioinformatics/btt703
|